Obesity and Addiction Medicine in Liver Disease: Translating Science Into Practice, Part 1—Understanding and Addressing Alcohol Use Disorder, Obesity, and Food Addiction
This course reviews timely topics regarding the management of alcohol use disorder (AUD), obesity, and food addiction. Experts highlight the striking behavioral and neurobiologic similarities between AUD and food addiction; key differences that impact clinical management; and the mechanisms underlying addiction in both contexts. Drawing on lessons from AUD treatment, the implications of food addiction in MASLD and alcohol-associated liver disease (ALD) are explored along with tips for effectively counseling patients on diet and lifestyle modifications. Using a case-based learning platform, presenters discuss multidisciplinary treatment strategies for both AUD and food addiction, and explore integration of addiction medicine principles into hepatology clinical practice. Speakers further highlight the complexities of addiction management, addressing challenges such as relapse, patient adherence, and the role of emerging therapies in improving outcomes. Experts also provide an update on the evolving clinical definition of obesity and the latest advancements in pharmacological treatments, particularly in the context of MASLD and ALD, including the incorporation of novel anti-obesity medications into hepatology practice to optimize patient outcomes. An interactive workshop highlighting the role of motivational interviewing for effecting behavioral change in obesity and AUD management follows. Participants practice key techniques for engaging patients in meaningful conversations about lifestyle modifications and treatment adherence. Drawing from successful models in primary care, experts share practical strategies for overcoming patient resistance and enhancing motivation for long-term health improvements.
NOTE: Continuing education credits earned at this session count as group 2 credits toward the American Board of Obesity Medicine qualifications for certification via the CME pathway.
The Addicted Liver: What Alcohol Use Disorder and Food Addiction Have in Common
Lamia Y. Haque, MD, MPH, Presenter
ALD
MASLD
2:20 PM - 2:40 PM
Nov
07
2025
San Diego, CA
Alcohol Use Disorder and Food Addiction Treatment: A Case-Based Learning Approach
Gene Im, MD, FAASLD, Presenter
ALD
MASLD
2:40 PM - 3:00 PM
Nov
07
2025
San Diego, CA
The New Definition of Obesity and Pharmacologic Interventions
Ashish Dhawan, MD, MSPH, Presenter
ALD
MASLD
3:00 PM - 3:30 PM
Nov
07
2025
San Diego, CA
Motivational Interviewing for Obesity and Alcohol Use Disorder: A Hands-On Workshop
Gerald Scott Winder, MD MSc FACLP, Presenter
ALD
MASLD
Objectives
Describe methods to address alcohol use disorder (AUD) and obesity in the context of liver disease by identifying effective screening tools for AUD and obesity in patients with MASLD or alcohol-associated liver disease (ALD).
Practice skills in applying brief interventions and motivational interviewing techniques to support behavioral change and improve patient outcomes.
Review implementation of evidence-based treatment strategies for AUD, obesity, and liver disease by evaluating pharmacologic and behavioral treatment options for AUD in the setting of ALD.
Summarize the latest pharmacologic and procedural interventions for obesity, including the use of anti-obesity medications and bariatric procedures, to optimize patient care and outcomes.
Discuss strategies to integrate lifestyle and multidisciplinary approaches into hepatology practice by developing personalized lifestyle intervention strategies, including diet and exercise, for patients with MASLD or ALD.